Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Description

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

Conditions

Polysubstance Abuse, Opioid Use, Tobacco Use

Study Overview

Study Details

Study overview

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

Motivational Interviewing (MI) and Mindfulness-Oriented Recovery Enhancement (MORE) for Tobacco Dependence and Other Drug Use in Methadone Treatment

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Condition
Polysubstance Abuse
Intervention / Treatment

-

Contacts and Locations

New Brunswick

Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States, 08901

Salt Lake City

University of Utah, Salt Lake City, Utah, United States, 84108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English-speaking
  • * Age ≥18
  • * Currently on methadone; and 4) currently smoke cigarettes.
  • * Severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
  • * Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
  • * Inability to attend or fully participate in intervention sessions or assessments
  • * Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
  • * Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
  • * Any contraindications for NRT
  • * Currently or soon planning to be pregnant or breastfeeding.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rutgers, The State University of New Jersey,

Nina Cooperman, PsyD, PRINCIPAL_INVESTIGATOR, Rutgers Robert Wood Johnson Medical School

Study Record Dates

2027-06-30